drugset / Trial / NCT00142389

Summary

This prospective randomized evaluation of pneumococcal vaccine immunization of pregnant mothers, followed by pneumococcal conjugate immunization of their children is designed to assess the effects of these strategies on the immunogenicity and safety of both vaccines. We hypothesize that maternal followed by infant immunization will be safe and will provide higher levels of antibody from birth through 12 months of age.

Timeline

Start
2004-08
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 7-valent pneumococcal vaccine Vaccine
Subject Pneumovax 23 Vaccine